Therefore, uPAR represents an appealing therapeutic target for asthma through links to altered expression and activity in the airway epithelium, where blocking selected functions of uPAR may be beneficial in halting/reversing airway remodeling changes observed. The gene discussed is PLAUR; the disease is asthma.